Clinical Observation of Exosomes in Patients After Q-switched Laser Surgery

Last updated: February 20, 2024
Sponsor: Nanjing First Hospital, Nanjing Medical University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Exosome liquid dressing

Clinical Study ID

NCT06279039
KY20230116-06
  • Ages 18-60
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

the goal of this half-face controlled study is to evaluate the effect of exosome-containing liquid dressings on the recovery of patients after Nd:YAG laser 532 treatment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • It meets the diagnostic criteria of seborrheic keratosis or freckle;
  • pepole are able to follow the treatment rules of the study and were followed up for 8weeks;
  • informed consent

Exclusion

Exclusion Criteria:

  • History of keloids ;
  • Pregnancy or lactation;
  • Any cosmetics containing growth factor-related ingredients used within 6 months priorto treatment
  • Patients with incomplete observation data and incomplete course of treatment wereexcluded

Study Design

Total Participants: 38
Treatment Group(s): 1
Primary Treatment: Exosome liquid dressing
Phase:
Study Start date:
September 01, 2022
Estimated Completion Date:
December 31, 2024

Study Description

The main objective was to collect patients with fleae or seborrheic keratosis after Q-switched laser treatment, and then to use exosomes or matrix on both sides of the face, and finally to evaluate the effect of exosomes on wound healing and prevention of post-inflammatory hyperpigmentation after Nd:YAG laser 532 treatment

Connect with a study center

  • Jie Dai

    Nanjing, Jiangsu 210006
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.